BackgroundAntibiotic-induced disturbances of the human microbiota have been implicated in the development of chronic autoimmune conditions. This study aimed to assess whether antibiotic use is associated with the onset of rheumatoid arthritis (RA).MethodsA nested case-control study was conducted utilising data from the primary care Clinical Practice Research Datalink (CPRD). Patients with an incident diagnosis of RA were identified (1995–2017). Each case was matched on age, gender, and general practice to =?5 controls without RA. Conditional logistic regression was used to examine previous antibiotic prescriptions and RA onset after controlling for confounding factors.ResultsWe identified 22,677 cases of RA, matched to 90,013 controls, with...
Objectives: This analysis set out to estimate the risk of opportunistic infection (OI) among patie...
AbstractObjectiveThe present article aims to provide a systematic review of the influence of anti-tu...
Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheum...
Background Antibiotic-induced disturbances of the human microbiota have been implicated in the deve...
OBJECTIVES:To test the hypothesis that prior antibiotics influences the risk of developing RA. METHO...
There is emerging evidence of the impact of infections on rheumatoid arthritis pathogenesis and flar...
Objectives Do recent infections affect the risk of rheumatoid arthritis (RA)? Methods We used the po...
Background: Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children and...
Objectives: To characterize the gut microbiota profile in rheumatoid arthritis (RA) patients and inv...
Objective: The main goal is to evaluate the clinical efficacy, safety, and tolerability of antibioti...
Rheumatoid arthritis (RA) is a complex autoimmune disease affecting 1–2 % of general worldwide popul...
Background: There has recently been increasing interest in the role of the human microbiome in disea...
Background: There has recently been increasing interest in the role of the human microbiome in disea...
OBJECTIVES: The aims of this study were to define the risk of serious bacterial infections in patie...
The human body contains millions of diverse microorganisms that collectively make up the human micro...
Objectives: This analysis set out to estimate the risk of opportunistic infection (OI) among patie...
AbstractObjectiveThe present article aims to provide a systematic review of the influence of anti-tu...
Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheum...
Background Antibiotic-induced disturbances of the human microbiota have been implicated in the deve...
OBJECTIVES:To test the hypothesis that prior antibiotics influences the risk of developing RA. METHO...
There is emerging evidence of the impact of infections on rheumatoid arthritis pathogenesis and flar...
Objectives Do recent infections affect the risk of rheumatoid arthritis (RA)? Methods We used the po...
Background: Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children and...
Objectives: To characterize the gut microbiota profile in rheumatoid arthritis (RA) patients and inv...
Objective: The main goal is to evaluate the clinical efficacy, safety, and tolerability of antibioti...
Rheumatoid arthritis (RA) is a complex autoimmune disease affecting 1–2 % of general worldwide popul...
Background: There has recently been increasing interest in the role of the human microbiome in disea...
Background: There has recently been increasing interest in the role of the human microbiome in disea...
OBJECTIVES: The aims of this study were to define the risk of serious bacterial infections in patie...
The human body contains millions of diverse microorganisms that collectively make up the human micro...
Objectives: This analysis set out to estimate the risk of opportunistic infection (OI) among patie...
AbstractObjectiveThe present article aims to provide a systematic review of the influence of anti-tu...
Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheum...